NCT01342263.
Methods |
Study design: mult‐ centre, single‐blinded, parallel individual randomised controlled trial in Canada Duration: 104 weeks Setting: primary and secondary clinics |
Participants |
Population: 234 adults recruited from Northern Health, Fraser Health, Interior Health, Vancouver Island Health, and Vancouver Coastal Health, Canada Baseline characteristics: unknown Inclusion criteria: ≥ 19 years of age; ≥ 2 of the following chronic diseases: CHF, DM, COPD, kidney disease, heart disease; Internet access; able to read, write, understand English Exclusion criteria: scheduled surgical procedures, not able to give informed consent, comorbidities interfering with management |
Interventions | Measurements taken at baseline and at 24 months Treatment arms
|
Outcomes |
Primary outcomes: hospital admissions, emergency room visits, hospital length of stay, physician visits, procedures (diagnostic and lab) Secondary outcomes: SF‐36, heiQ, satisfaction (participants and providers), social support, EQ‐5D‐5L, adhering to intervention |
Notes |
Funding: Simon Fraser University Other identifier:NCT01342263 |